embryonic stem cell-derived retinal pigmented epithelial cells therapy (Karolinska Institutet)

N/A

Report date: 2025/06/11 10:36:30

Base Information

Drug Nameembryonic stem cell-derived retinal pigmented epithelial cells therapy (Karolinska Institutet)
Drug Alias NameCellThRPE1embryonic retinal stem cells therapy (karolinska Institutet)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Embryonic stem cells therapyCell and gene therapy > Cell therapy > Stem cell therapy > Retinal stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsGeographic Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKarolinska Institutet
China Registration ClassN/A

Develop Information

Active CompaniesNovo Nordisk A/SKarolinska Institutet
Inactive CompaniesN/A
Active IndicationsGeographic Atrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A